NCT04912414 is a NA clinical trial of Brief Family Therapy (BFT) in Patient Engagement, sponsored by University of Rwanda.

Who is sponsoring NCT04912414?

NCT04912414 is sponsored by University of Rwanda.

What drugs are being tested in NCT04912414?

Interventions in NCT04912414: Brief Family Therapy (BFT).

What condition does NCT04912414 study?

NCT04912414 studies Patient Engagement.

Is NCT04912414 still recruiting?

NCT04912414 is currently completed. Last updated 3 June 2021.

Last reviewed 2021-06-03 · How we verify

NCT04912414

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Brief Family Therapy (BFT) for the Treatment of Psychosomatic Symptoms in Rwanda

Completed NA Last updated 3 June 2021

What this trial tests

NA trial testing Brief Family Therapy (BFT) in Patient Engagement in 120 participants. Completed in 30 December 2020.

Timeline

1 March 2020

Primary endpoint
30 July 2020

30 December 2020

Quick facts

Lead sponsor	University of Rwanda
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	120
Start date	1 March 2020
Primary completion	30 July 2020
Estimated completion	30 December 2020
Sites	2 locations across Rwanda

Drugs / interventions tested

Brief Family Therapy (BFT)

Conditions studied

Patient Engagement — all drugs for Patient Engagement →

Sponsor

University of Rwanda

Who can join

Adults 18 to 59, any sex, with Patient Engagement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Mental health is fundamental part of the human being worldwide taken as the driver of all daily activities of the people. Psychosomatic disorders are the psychological diseases that are the burden in mental health worldwide. These diseases characterized by the medically unexplained symptomatology (MUS) are considered as a comprehensive, interdisciplinary framework for assessment of psychological factors affecting individual vulnerability, as well as course and outcome of illness; biopsychosocial consideration of patient care in clinical practice; specialist interventions to integrate psychological therapies in the prevention, treatment, and rehabilitation of medical disease. This psychosomatic symptomatology is highly prevalent in developing countries. Prior studies stated that Brief family therapy (BFT) is an effective for MUS. Some possible reasons could be solving conflicts and interpersonal problems by means of training certain skills such as problem solving, developing relationships with others, effective coping, assertiveness and positive thinking. This quasi-experimental design investigates whether BFT can reduce psychosomatic symptoms in Kibungo referral hospital of Eastern Province, Rwanda. Experimental group enroll 60 patients who will be followed up during 2 months. Control group enroll 60 patients. Participants from experimental group will attend 8 sessions of BFT. Statistical analyses will be performed using the SPSS software version 22. As recommended by the declaration of Helsinki, confidentiality and voluntariness were ensured. Informed consents were obtained from the participants. Paired-samples t-test will be used for assessing the means differences between two groups before and after the BFT. 95% of confidence intervals and 5% of statistical significance are applied. In the baseline, sociodemographic questionnaire and psychometric tools will be provided. The psychometric tools will be used in the baseline and at the end of BFT sessions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Patient Engagement

Currently open trials in the same condition.

NCT06755710 — Patient Engagement in PTSD Treatment (PEP) · NA · recruiting
NCT05732779 — Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant R · NA · recruiting
NCT04949568 — Self-Management and Glycemic Control in Adult Haitian Immigrants With Type 2 Diabetes · NA · active not recruiting
NCT05780164 — Improving Access to Lung Cancer Clinical Trials · recruiting
NCT05989477 — At-home Breast Oncology Care Delivered With E-health Solutions · NA · recruiting

Other University of Rwanda trials

Trials by the same sponsor.

NCT06711848 — Testing and Comparing the Impacts of Mhealth-Based and Web-Based Education on Oral Cancer · NA · not yet recruiting
NCT06959134 — Community Health Workers-led Multicomponent Intervention for Hypertension Control in Rwanda · NA · completed
NCT06768502 — Effectiveness of Community-based Approach in Reducing the Intimate Partner Violence (IPV) Exposure and Outcome · NA · completed
NCT03595852 — Antibiotic Prophylaxis in Clean Surgery. Impact on Surgical Site Infection · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04912414 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Rwanda
Last refreshed: 3 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04912414.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing